Antiangiogenic therapy--evolving view based on clinical trial results.

Nature Reviews. Clinical Oncology
Gordon C JaysonLee M Ellis

Abstract

Antiangiogenic therapies that target VEGF or its receptors have become a mainstay of cancer therapy in multiple malignancies. However, the clinical efficacy of these agents is less than originally anticipated and, in most settings, requires the addition of cytotoxic chemotherapy suggesting that, as for other targeted therapies, VEGF inhibitors will require selection of patient subpopulations to achieve maximal clinical benefit. Without the identification and use of predictive biomarkers for VEGF-targeted agents, and other agents that target the vasculature, further improvements in current clinical outcomes are unlikely. Exciting new data presented in 2011 at the ESMO conference showed that retrospective evaluation of plasma concentrations of VEGF-A predicted progression-free survival and/or overall survival benefit from bevacizumab in phase III trials in certain tumour types; prospective evaluation of the assay is required. This endeavour should be followed by further biomarker research, requiring inter-laboratory collaboration and high-quality, adequately powered clinical trials.

References

Mar 1, 1993·Journal of Pediatric Surgery·H Brem, J Folkman
Dec 6, 1997·Nature·V I PidoplichkoJ A Dani
Aug 2, 2003·The New England Journal of Medicine·James C YangSteven A Rosenberg
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William P J LeendersRobert de Waal
Nov 19, 2004·Cancer Research·Kyoko HidaMichael Klagsbrun
Dec 3, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sarah E DuffGordon C Jayson
Dec 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adrian M JubbHartmut Koeppen
Jan 5, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suparna Bonthala WedamSandra M Swain
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Jan 11, 2007·British Journal of Cancer·J P B O'ConnorG C Jayson
Jun 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alan JacksonGordon C Jayson
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shirin Khambata-FordDavid J Mauro
Aug 1, 2007·Nature Biotechnology·Farbod ShojaeiNapoleone Ferrara
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen A CannistraWilliam McGuire
Feb 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Farbod ShojaeiNapoleone Ferrara
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzJim Cassidy
Jul 4, 2008·Nature Reviews. Cancer·Lee M Ellis, Daniel J Hicklin
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Oct 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Axel GrotheyMark Kozloff
Mar 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemMalcolm J Moore
Apr 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Farbod ShojaeiNapoleone Ferrara
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James P B O'ConnorGordon C Jayson
Dec 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emer O HanrahanJohn V Heymach
Dec 17, 2009·British Journal of Cancer·N MurukeshG C Jayson
Mar 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio ScagliottiNasser Hanna
Jul 8, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Neil R SmithChris Womack
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hedy Lee KindlerRichard M Goldberg
Nov 26, 2010·Nature Medicine·Damian MediciBjorn R Olsen
Feb 11, 2011·The New England Journal of Medicine·Eric RaymondPhilippe Ruszniewski
Feb 11, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alessandra FabiMarcella Mottolese
May 18, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David R SpigelJohn D Hainsworth

❮ Previous
Next ❯

Citations

Sep 27, 2012·Journal of Mammary Gland Biology and Neoplasia·Robert S Kerbel
Aug 2, 2012·Nature Reviews. Clinical Oncology·Adriana AlbiniWilliam W Li
May 15, 2013·Journal of the National Cancer Institute·Stacey D Finley, Aleksander S Popel
Aug 16, 2013·The Journal of Clinical Investigation·Leisa JohnsonPriti S Hegde
Jun 28, 2013·PloS One·Wan Hua TanFeilim Mac Gabhann
Nov 15, 2012·Future Oncology·Neel PatelKatherine A Vallis
Mar 13, 2014·Biochemical Pharmacology·Luigi QuintieriStefano Indraccolo
Oct 1, 2013·Pharmacology & Therapeutics·Giannis MountziosPeter Carmeliet
Jun 24, 2014·Women's Health·Pratibha S Binder, David G Mutch
Jul 9, 2014·The Journal of Clinical Investigation·Miguel Manuel MurilloJulian Downward
Jan 16, 2014·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Jennifer PasquierArash Rafii
Nov 20, 2014·Future Medicinal Chemistry·Chao DingYuyang Jiang
Apr 4, 2015·Science·Johanna A Joyce, Douglas T Fearon
Jan 7, 2014·Expert Opinion on Biological Therapy·Gennaro DanieleFrancesco Perrone
Apr 3, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Charles M RudinJun O Liu
Feb 13, 2016·Frontiers in Oncology·Stefano Indraccolo, Wolfgang Mueller-Klieser
Dec 19, 2015·Cancer Cell·Lorenzo GalluzziGuido Kroemer
Dec 2, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yan LiGang Chen
Nov 29, 2015·Magnetic Resonance Imaging Clinics of North America·Roberto García-FigueirasSandra Baleato-González
Mar 13, 2014·International Journal of Cancer. Journal International Du Cancer·Richard BachelierPhilippe Clézardin
Jan 1, 2014·International Journal of Cancer. Journal International Du Cancer·Maressa A BruhnUNKNOWN BHI in collaboration with AGITG
Sep 4, 2015·Cancer Metastasis Reviews·Isaiah J Fidler, Margaret L Kripke
Jul 6, 2014·Investigational New Drugs·Yingmiao LiuAndrew B Nixon
Nov 18, 2014·Biochemical Society Transactions·Gordon C JaysonEgle Avizienyte
Jul 28, 2012·Expert Opinion on Therapeutic Targets·Nancy M Benight, Susan E Waltz
Dec 30, 2014·Trends in Cell Biology·Florian Klemm, Johanna A Joyce
Apr 28, 2016·Nature Reviews. Clinical Oncology·Yuval Shaked
Jul 1, 2016·Chinese Journal of Cancer·Ilaria Fuso NeriniRaffaella Giavazzi
Oct 30, 2015·Journal of the Royal Society, Interface·H HatzikirouM Meyer-Hermann
Feb 3, 2018·International Journal of Molecular Sciences·Bryce LaFoyaAllan R Albig
Dec 18, 2018·Expert Opinion on Therapeutic Patents·Giuseppina De Simone
Oct 24, 2018·Genes, Chromosomes & Cancer·Yajuan LiChunru Lin
Nov 2, 2014·EMBO Molecular Medicine·John Ml EbosRobert S Kerbel
Jul 23, 2015·Archives of Pharmacal Research·Ho Jeong KwonGyörgy Marko-Varga
Aug 1, 2013·The Oncologist·Sumita S BhattaMichael L Maitland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.